QIAGEN and AstraZeneca Expand Pact to Develop CDx in Chronic Diseases

QIAGEN N.V. QGEN has expanded its Master Collaboration Agreement with AstraZeneca AZN to develop and commercialize companion diagnostics (CDx) for AstraZeneca’s future therapies targeting chronic diseases. The collaboration w https://www.nasdaq.com/articles/qiagen-and-astrazeneca-expand-pact-develop-cdx-chronic-diseases